ATA164477A - Verfahren zur herstellung von neuen derivaten des 2,3-dihydroimidazo (2,1-b)thiazols - Google Patents

Verfahren zur herstellung von neuen derivaten des 2,3-dihydroimidazo (2,1-b)thiazols

Info

Publication number
ATA164477A
ATA164477A AT164477A AT164477A ATA164477A AT A164477 A ATA164477 A AT A164477A AT 164477 A AT164477 A AT 164477A AT 164477 A AT164477 A AT 164477A AT A164477 A ATA164477 A AT A164477A
Authority
AT
Austria
Prior art keywords
dihydroimidazo
thiazol
producing new
new derivatives
derivatives
Prior art date
Application number
AT164477A
Other languages
English (en)
Other versions
AT352716B (de
Original Assignee
Metabio Fa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabio Fa filed Critical Metabio Fa
Publication of ATA164477A publication Critical patent/ATA164477A/de
Application granted granted Critical
Publication of AT352716B publication Critical patent/AT352716B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT164477A 1976-03-10 1977-03-10 Verfahren zur herstellung von neuen derivaten des 2,3-dihydroimidazo (2,1-b)thiazols AT352716B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9517/76A GB1541321A (en) 1976-03-10 1976-03-10 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
ATA164477A true ATA164477A (de) 1979-03-15
AT352716B AT352716B (de) 1979-10-10

Family

ID=9873507

Family Applications (1)

Application Number Title Priority Date Filing Date
AT164477A AT352716B (de) 1976-03-10 1977-03-10 Verfahren zur herstellung von neuen derivaten des 2,3-dihydroimidazo (2,1-b)thiazols

Country Status (28)

Country Link
US (1) US4110460A (de)
JP (1) JPS5927357B2 (de)
AT (1) AT352716B (de)
AU (1) AU503912B2 (de)
BE (1) BE852259A (de)
BG (1) BG28262A3 (de)
CA (1) CA1074324A (de)
CH (1) CH598267A5 (de)
CS (1) CS190341B2 (de)
DE (1) DE2709639A1 (de)
DK (1) DK144702C (de)
ES (1) ES456575A1 (de)
FI (1) FI62313C (de)
FR (1) FR2343748A1 (de)
GB (1) GB1541321A (de)
HU (1) HU172685B (de)
IE (1) IE44280B1 (de)
IL (1) IL51581A (de)
LU (1) LU76879A1 (de)
NL (1) NL7702446A (de)
NO (1) NO150884C (de)
PL (1) PL102603B1 (de)
PT (1) PT66278B (de)
RO (1) RO71301A (de)
SE (1) SE431653B (de)
SU (1) SU629882A3 (de)
YU (1) YU61977A (de)
ZA (1) ZA771303B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4204067A (en) * 1976-09-24 1980-05-20 Adhikary Parimal K Derivatives of imidazo[2,1-b] thiazole
US4263311A (en) * 1976-09-27 1981-04-21 Smithkline Corporation 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
US4153706A (en) 1978-02-13 1979-05-08 Smithkline Corporation 6-Hydroxy-5,6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
PL221188A1 (de) * 1979-01-05 1980-12-01 Ciba Geigy Ag
US4364942A (en) * 1979-06-21 1982-12-21 Janssen Pharmaceutica N.V. 2,3-Dihydro-imidazo (2,1-b)benzothiazoles compositions useful as anti-parkinsonism agents
FR2463774A1 (fr) * 1979-08-21 1981-02-27 Yamanouchi Pharma Co Ltd Derives du 2-phenylimidazo(2,1-b)benzothiazole
FR2479831A1 (fr) * 1980-04-08 1981-10-09 Synthelabo Derives de thiazole, leur preparation et leur application en therapeutique
US4327221A (en) * 1980-10-15 1982-04-27 American Home Products Corporation 2-Substituted-3-hydroxythiazolo(2,3-8)-thiazolium salts and mesoionic didehydro derivatives thereof
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
ZW24186A1 (en) * 1985-12-12 1987-07-08 Smithkline Beckman Corp Inhibition of the 5-lipoxygenase pathway
US5134150A (en) * 1985-12-12 1992-07-28 Smithkline Beecham Corporation Inhibition of the 5-lipoxygenase pathway
US4751310A (en) * 1985-12-12 1988-06-14 Smithkline Beckman Corporation Inhibition of the 5-lipoxygenase pathway
US4719218A (en) * 1985-12-12 1988-01-12 Smithkline Beckman Corporation Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor
US5145858A (en) * 1985-12-12 1992-09-08 Smithkline Beecham Corp. Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4794114A (en) * 1986-08-19 1988-12-27 Smithkline Beckman Corporation Inhibition of interleukin-1 production by monocytes and/or macrophages
US5630014A (en) * 1993-10-27 1997-05-13 Nec Corporation Gain controller with automatic adjustment using integration energy values
US6127387A (en) * 1996-12-10 2000-10-03 Thomas Jefferson University Use of CD4-binding small molecules to inhibit immune responses
WO2007034282A2 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (de) * 1964-05-11
US3455924A (en) * 1967-02-08 1969-07-15 Upjohn Co Dianisylimidazoles
NL164285C (nl) * 1968-01-09 1980-12-15 Rhone Poulenc Sa Werkwijze ter bereiding van een farmaceutisch preparaat, dat een imidazoÿ2.1-bÿthiazoolderivaat bevat, de gevormde farmaceutische preparaten, alsmede werkwijze voor het bereiden van dit imidazoÿ2.1-bÿthiazoolderivaat.

Also Published As

Publication number Publication date
AU503912B2 (en) 1979-09-27
DK144702B (da) 1982-05-17
YU61977A (en) 1982-06-30
CA1074324A (en) 1980-03-25
FI62313B (fi) 1982-08-31
DK104677A (da) 1977-09-11
JPS52136195A (en) 1977-11-14
GB1541321A (en) 1979-02-28
ZA771303B (en) 1978-01-25
SU629882A3 (ru) 1978-10-25
NO150884B (no) 1984-09-24
NO150884C (no) 1985-01-09
FR2343748A1 (fr) 1977-10-07
FI770759A (de) 1977-09-11
DK144702C (da) 1982-10-11
SE7702503L (sv) 1977-09-11
LU76879A1 (de) 1977-07-12
PT66278B (fr) 1978-08-08
CH598267A5 (de) 1978-04-28
IE44280B1 (en) 1981-09-23
JPS5927357B2 (ja) 1984-07-05
CS190341B2 (en) 1979-05-31
ES456575A1 (es) 1978-02-16
PT66278A (fr) 1977-04-01
AT352716B (de) 1979-10-10
DE2709639A1 (de) 1977-09-15
RO71301A (ro) 1981-11-24
HU172685B (hu) 1978-11-28
BE852259A (fr) 1977-09-09
FI62313C (fi) 1982-12-10
NO770841L (no) 1977-09-13
FR2343748B1 (de) 1980-07-18
IL51581A (en) 1980-02-29
IE44280L (en) 1977-09-10
US4110460A (en) 1978-08-29
PL102603B1 (pl) 1979-04-30
NL7702446A (nl) 1977-09-13
IL51581A0 (en) 1977-05-31
SE431653B (sv) 1984-02-20
AU2315677A (en) 1978-09-14
BG28262A3 (en) 1980-03-25

Similar Documents

Publication Publication Date Title
AT351164B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT352716B (de) Verfahren zur herstellung von neuen derivaten des 2,3-dihydroimidazo (2,1-b)thiazols
ATA425280A (de) Verfahren zur herstellung von neuen 2-phenyl-imidazo(2.1-b)-benzothiazolderivaten
AT352875B (de) Verfahren zur herstellung von neuen 4-oxa-1- azabicyclo-(3,2,0)heptan-7-onderivaten
AT357274B (de) Verfahren zur herstellung von neuen derivaten des 20,21-dinoreburnamenins
AT357693B (de) Verfahren zur herstellung von neuen ergolen- -derivaten
AT352120B (de) Verfahren zur herstellung von neuen benzoxocin- derivaten
AT356655B (de) Verfahren zur herstellung von neuen benzodia- zepinderivaten
AT375941B (de) Verfahren zur herstellung von neuen 1-aminopyrazolo (1,5-c) chinazolinderivaten
AT358202B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
AT347937B (de) Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten
AT350051B (de) Verfahren zur herstellung von neuen derivaten von 5-amino-1,2,4-oxadiazolen
AT351677B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT361928B (de) Verfahren zur herstellung von neuen chinolonderivaten
AT358189B (de) Verfahren zur herstellung von neuen aspidosper- midinen
ATA64684A (de) Verfahren zur herstellung von neuen thiadiazolderivaten
DD129910A5 (de) Verfahren zur herstellung von neuen morpholinderivaten
ATA893377A (de) Verfahren zur herstellung von neuen thieno- thiazinderivaten
AT362349B (de) Verfahren zur herstellung von neuen 3-amino-2- -hydroxypropoxyaryl-derivaten
AT356301B (de) Verfahren zur herstellung von neuen d-homo- steroiden
ATA216083A (de) Verfahren zur herstellung von neuen 1-nitropyrazolo(1,5-c)chinazolinderivaten
AT355204B (de) Verfahren zur herstellung von neuen 7-(4- carboxybutyramido)-7-methoxycephalosporin- derivaten
AT373603B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
ATA796779A (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
ATA796979A (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee